Gain Therapeutics (GANX) Price to Sales (2021 - 2026)
Gain Therapeutics' (GANX) Price to Sales was 771.06 for Q4 2023, up 190.4% from 265.47 a year earlier and up 1.5% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Price to Sales (2021 - 2026) Analysis & Trends
Dating back to Q1 2021, Gain Therapeutics' Price to Sales record includes 12 quarters.
- By year, Price to Sales came in at 265.47 in FY2022 (-32.1%) and 391.09 in FY2021.
- Five-year quarterly Price to Sales spans a low of 203.08 in Q2 2022 and a high of 5788.51 in Q1 2021.
- Year over year, Price to Sales has now increased in each of the last four quarters, with growth averaging 80.1% over the last eight quarters.
- The high point for year-over-year Price to Sales in five years was Q2 2023 (growth of 405.0%); the low point was Q1 2022 (a decline of 95.9%).
- Per Business Quant data, the three quarters before Q4 2023 came in at 759.84 (Q3 2023), 1025.60 (Q2 2023) and 387.67 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Gain Therapeutics | 54.24 Mn | -5.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 278.84 |
| Mar 31, 2026 | 277.50 |
| Dec 31, 2025 | 434.37 |
| Sep 30, 2025 | 395.38 |
| Jun 30, 2025 | 667.48 |
| Mar 31, 2025 | 1,358.60 |
| Dec 31, 2023 | 771.06 |
| Sep 30, 2023 | 759.84 |
| Jun 30, 2023 | 1,025.60 |
| Mar 31, 2023 | 387.67 |
| Dec 31, 2022 | 265.47 |
| Sep 30, 2022 | 211.33 |
| Jun 30, 2022 | 203.08 |
| Mar 31, 2022 | 237.40 |
| Dec 31, 2021 | 391.08 |
| Sep 30, 2021 | 675.99 |
| Jun 30, 2021 | 1,076.97 |
| Mar 31, 2021 | 5,788.51 |
API Access
Gain Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();